CURE

Every FDA Oncology Approval From November 2025

In November 2025, the U.S. Food and Drug Administration (FDA) issued several approvals across oncology and supportive care.

FDA approves Padcev for muscle-invasive bladder cancer

The U.S. Food and Drug Administration has approved Pfizer's Padcev (enfortumab vedotin-ejfv), a Nectin-4 directed ...
ABC 10News San Diego

Logan Heights mother receives prosthetic arm after surviving flesh-eating disease

Logan Heights mother Arisbeth Munoz receives prosthetic arm nearly a year after surviving flesh-eating disease that required ...
Rheumatology Advisor

FDA Approves Denosumab Biosimilars Osvyrti, Jubereq

The FDA has approved Osvyrti (denosumab-desu), a biosimilar to Prolia (denosumab), and Jubereq (denosumab-desu), a biosimilar to Xgeva (denosumab).
MarketWatch

Captiva Spine announces FDA clearance for Flat-Panel C-Arm Calibrators and AI-Assisted Registration for WatchTower Spine Navigation, advancing future-ready access

The MarketWatch News Department was not involved in the creation of this content. Captiva Spine announces FDA clearance for Flat-Panel C-Arm Calibrators and AI-Assisted Registration for WatchTower ...
Hosted on MSN

Roche Receives FDA Approval for Kidney Inflammation Drug

Roche Holding said the Food and Drug Administration approved a drug for the treatment of adults with lupus nephritis, a potentially life-threatening autoimmune disease that commonly affects the ...
The New York Times

Source: Goldman Sachs to become majority stakeholder of Excel Sports Management

Goldman Sachs will make an investment into Excel that will make it a majority stakeholder, according to one person briefed on the deal. Michael M. Santiago / Getty Images Goldman Sachs has taken an ...